Patents by Inventor Rudolph WILHELM

Rudolph WILHELM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGES TO THE RECTUM
    Publication number: 20230364113
    Abstract: Disclosed is a storage-stable pharmaceutical formulation for rectal administration, containing budesonide or a pharmaceutically compatible salt or derivative thereof, and at least 80 wt % of a solid fat or a mixture of different solid fats, based on the total weight of the formulation, as well as at least one anti-oxidation agent that is compatible therewith.
    Type: Application
    Filed: July 12, 2023
    Publication date: November 16, 2023
    Inventors: Rudolph WILHELM, Markus PRÖLS, Roland GREINWALD, Ralf MOHRBACHER
  • Pharmaceutical formulation for the treatment of inflammatory changes to the rectum
    Patent number: 11738032
    Abstract: Disclosed is a storage-stable pharmaceutical formulation for rectal administration, containing budesonide or a pharmaceutically compatible salt or derivative thereof, and at least 80 wt % of a solid fat or a mixture of different solid fats, based on the total weight of the formulation, as well as at least one anti-oxidation agent that is compatible therewith.
    Type: Grant
    Filed: November 10, 2020
    Date of Patent: August 29, 2023
    Assignee: Dr. Falk Pharma GmbH
    Inventors: Rudolph Wilhelm, Markus Pröls, Roland Greinwald, Ralf Mohrbacher
  • Optimized high-dose mesalazine-containing tablet
    Patent number: 11135159
    Abstract: The present invention relates to an oral enteric high-dose tablet comprising mesalazine as the active substance as well as its use.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: October 5, 2021
    Inventors: Rudolph Wilhelm, Markus Pröls, Roland Greinwald, Tanju Nacak
  • PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGES TO THE RECTUM
    Publication number: 20210100819
    Abstract: Disclosed is a storage-stable pharmaceutical formulation for rectal administration, containing budesonide or a pharmaceutically compatible salt or derivative thereof, and at least 80 wt % of a solid fat or a mixture of different solid fats, based on the total weight of the formulation, as well as at least one anti-oxidation agent that is compatible therewith.
    Type: Application
    Filed: November 10, 2020
    Publication date: April 8, 2021
    Inventors: Rudolph WILHELM, Markus PRÖLS, Roland GREINWALD, Ralf MOHRBACHER
  • Pharmaceutical formulation for the treatment of inflammatory changes to the rectum
    Patent number: 10905699
    Abstract: Disclosed is a storage-stable pharmaceutical formulation for rectal administration, containing budesonide or a pharmaceutically compatible salt or derivative thereof, and at least 80 wt % of a solid fat or a mixture of different solid fats, based on the total weight of the formulation, as well as at least one anti-oxidation agent that is compatible therewith.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: February 2, 2021
    Assignee: Dr. Falk Pharma GmbH
    Inventors: Rudolph Wilhelm, Markus Pröls, Roland Greinwald, Ralf Mohrbacher
  • OPTIMISED HIGH-DOSE MESALAZINE-CONTAINING TABLET
    Publication number: 20180311155
    Abstract: The present invention relates to an oral enteric high-dose tablet comprising mesalazine as the active substance as well as its use.
    Type: Application
    Filed: October 21, 2016
    Publication date: November 1, 2018
    Inventors: Rudolph WILHELM, Markus PRÖLS, Roland GREINWALD, Tanju NACAK
  • PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGES TO THE RECTUM
    Publication number: 20180200268
    Abstract: Disclosed is a storage-stable pharmaceutical formulation for rectal administration, containing budesonide or a pharmaceutically compatible salt or derivative thereof, and at least 80 wt % of a solid fat or a mixture of different solid fats, based on the total weight of the formulation, as well as at least one anti-oxidation agent that is compatible therewith.
    Type: Application
    Filed: June 28, 2016
    Publication date: July 19, 2018
    Inventors: Rudolph WILHELM, Markus PRÖLS, Roland GREINWALD, Ralf MOHRBACHER